Physician profile
Abigail Glick
NPI 1609519503
$7,369.11
in general payments reported to CMS, 2019-2025
14 companies · $2,263 in 2025
The $2,263 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $304 · 2023: $1,594 · 2024: $3,208 · 2025: $2,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,079 · Travel and Lodging: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,078.74 |
| Travel and Lodging | $986.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,787.36 | 2022-2025 | Total30, Dailies Total1, Precision7 |
| Biotissue Holdings INC. | $1,535.24 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $723.68 | 2022-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $537.05 | 2022-2025 | Infuse, Biotrue One Day, Infuse Multifocal |
| Sight Sciences, INC. | $528.17 | 2024-2025 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $488.75 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $222.06 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $160.52 | 2023-2025 | Tyrvaya, Ryzumvi |
| Visioneering Technologies, INC. | $105.11 | 2023-2024 | |
| Abbvie INC. | $99.52 | 2022-2025 | Vuity |
| Dompe US, INC. | $86.67 | 2025 | Oxervate |
| Coopervision INC. | $43.86 | 2024-2025 | Myday Contact Lens |
| Eyevance Pharmaceuticals LLC | $30.92 | 2022 | |
| Horizon Therapeutics Plc | $20.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Glick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.